mardi 29 mars 2016

Onco Actu du 29 mars 2016

1. Biologie

The Smallest Viable Genome Is Very Weird [In the Pipeline]

How Cancer Stem Cells Thrive When Oxygen Is Scarce [Johns Hopkins]

3.1 Tabac

Cigarettes Cheaper than E-cigarettes in 44 of 45 Countries Studied [ACS]

4. Dépistage, diagnostic et pronostic

BIDMC Researchers Discover Early Indicators of Pancreatic Cancer [Beth Israel Deaconess Medical Center]

Cancer patients could see if chemotherapy is working in real-time [The Telegraph]

4.1 Dép., diag. & prono. - Prostate

Drs. Ruth Etzioni and Joshua Roth lead economic analysis of PSA screening and selective treatment strategies for prostate cancer [Fred Hutch]

4.2 Dép., diag. & prono. - Génome

Cancer Treatment's New Direction [Wall Street Journal]

5. Traitements

Scientists identify potential treatment options for rare cancer [The Institute of Cancer Research]

Breast Cancer Resistance to CDK4/6 Inhibitors Arises in Many Ways [AACR]

5.2.3 Pharma - économie

IMS: Healthcare can save $110B on biosims--if payers kick their policies into gear, that is [FiercePharma]

Biosimilar drugs could save up to $110 billion by 2020: IMS [Reuters]

5.3 Traitements - FDA, EMA,...

FDA Shares Views on Juvenile Animal Studies for Oncology Drugs [RAPS]

5.4 Traitements - Economie

Buying Costly Drugs On The Installment Plan: Could It Work? [NPR]

Value Pricing For Drugs: Whose Value, What Price? [Health Affairs]

U.S. spends $3 billion a year on unused cancer drugs [Reuters]

5.5 ASCO

Clifford Hudis Named CEO of ASCO [The Cancer Letter]

6. Lutte contre les cancers

Sneak preview: Inside the new facility that hopes to revolutionise radiotherapy [The Institute of Cancer Research]

Yoga 'cures cancer,' claims senior Indian government official [The Telegraph]

6.1 Observation

Patients with terminal cancer live longer when cared for at home [STAT]

6.10 Politiques

Sanders, other lawmakers seek NIH hearing to override drug patent [STAT]

U.S. lawmakers want health agencies to lower prostate cancer drug cost [Reuters]